tiprankstipranks

DE:1FU6 ETF Price & Analysis

Compare

1FU6 ETF Chart & Stats

ETF Overview

First Trust NYSE Arca Biotechnology UCITS ETF

The First Trust NYSE Arca Biotechnology UCITS ETF, trading under the ticker DE:1FU6, is a specialized investment vehicle designed for those seeking targeted exposure within the dynamic health care sector. This ETF zeroes in on the biotechnology niche, a frontier of medical innovation where groundbreaking developments shape the future of health care. By investing in this fund, investors gain access to a curated portfolio of companies at the forefront of biotech advancements, ranging from genetic sequencing to cutting-edge pharmaceuticals and beyond. This ETF is not only a gateway to potential high-growth opportunities but also a means to align one's investment strategy with the rapidly evolving landscape of biotechnology. Suitable for investors with a keen interest in health care innovations, the First Trust NYSE Arca Biotechnology UCITS ETF offers a strategic approach to capturing the potential upside of the biotech revolution while navigating the complexities of this specialized market.

First Trust NYSE Arca Biotechnology UCITS ETF (1FU6) Fund Flow Chart

First Trust NYSE Arca Biotechnology UCITS ETF (1FU6) 1 year Net Flows: €2M

1FU6 ETF FAQ

What was DE:1FU6’s price range in the past 12 months?
DE:1FU6 lowest ETF price was €16.10 and its highest was €22.00 in the past 12 months.
    What is the AUM of DE:1FU6?
    As of Feb 20, 2025 The AUM of DE:1FU6 is 8.73M.
      Is DE:1FU6 overvalued?
      According to Wall Street analysts DE:1FU6’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does DE:1FU6 pay dividends?
        DE:1FU6 does not currently pay dividends.
        How many shares outstanding does DE:1FU6 have?
        Currently, no data Available
        Which hedge fund is a major shareholder of DE:1FU6?
        Currently, no hedge funds are holding shares in DE:1FU6

        1FU6 ETF Smart Score

        For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

        Top 10 Holdings

        Name
        Weight %
        Corcept Therapeutics
        4.74%
        Intra-Cellular Therapies
        4.36%
        Beigene, Ltd.
        4.31%
        Alkermes plc
        4.10%
        Gilead Sciences
        3.85%
        Vertex Pharmaceuticals Inc.
        3.70%
        ACADIA Pharmaceuticals Inc.
        3.67%
        Amgen Inc
        3.61%
        Halozyme Therapeutics
        3.52%
        Mettler-toledo International
        3.46%
        Total39.33%
        See All Holdings
        Popular ETFs
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis